These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 22374733)

  • 1. Organophosphorus hydrolase as an in vivo catalytic nerve agent bioscavenger.
    Wales ME; Reeves TE
    Drug Test Anal; 2012; 4(3-4):271-81. PubMed ID: 22374733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In search of a catalytic bioscavenger for the prophylaxis of nerve agent toxicity.
    diTargiani RC; Chandrasekaran L; Belinskaya T; Saxena A
    Chem Biol Interact; 2010 Sep; 187(1-3):349-54. PubMed ID: 20176006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of the rePON1 mutant IIG1 to prevent cyclosarin toxicity in vivo and to detoxify structurally different nerve agents in vitro.
    Worek F; Seeger T; Goldsmith M; Ashani Y; Leader H; Sussman JS; Tawfik D; Thiermann H; Wille T
    Arch Toxicol; 2014 Jun; 88(6):1257-66. PubMed ID: 24477626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progress in the development of enzyme-based nerve agent bioscavengers.
    Nachon F; Brazzolotto X; Trovaslet M; Masson P
    Chem Biol Interact; 2013 Dec; 206(3):536-44. PubMed ID: 23811386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A simple and highly effective catalytic nanozyme scavenger for organophosphorus neurotoxins.
    Efremenko EN; Lyagin IV; Klyachko NL; Bronich T; Zavyalova NV; Jiang Y; Kabanov AV
    J Control Release; 2017 Feb; 247():175-181. PubMed ID: 28043864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Organophosphate hydrolases as catalytic bioscavengers of organophosphorus nerve agents.
    Trovaslet-Leroy M; Musilova L; Renault F; Brazzolotto X; Misik J; Novotny L; Froment MT; Gillon E; Loiodice M; Verdier L; Masson P; Rochu D; Jun D; Nachon F
    Toxicol Lett; 2011 Sep; 206(1):14-23. PubMed ID: 21683774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing protection against OP pesticides and nerve agents provided by wild-type HuPON1 purified from Trichoplusia ni larvae or induced via adenoviral infection.
    Hodgins SM; Kasten SA; Harrison J; Otto TC; Oliver ZP; Rezk P; Reeves TE; Chilukuri N; Cerasoli DM
    Chem Biol Interact; 2013 Mar; 203(1):177-80. PubMed ID: 23123254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and characterization of novel catalytic bioscavengers of organophosphorus nerve agents.
    Otto TC; Scott JR; Kauffman MA; Hodgins SM; Ditargiani RC; Hughes JH; Sarricks EP; Saturday GA; Hamilton TA; Cerasoli DM
    Chem Biol Interact; 2013 Mar; 203(1):186-90. PubMed ID: 23041042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Engineered Recombinant PON1-OPH Fusion Hybrids: Potentially Effective Catalytic Bioscavengers against Organophosphorus Nerve Agent Analogs.
    Lee N; Yun H; Lee C; Lee Y; Kim E; Kim S; Jeon H; Yu C; Rho J
    J Microbiol Biotechnol; 2021 Jan; 31(1):144-153. PubMed ID: 33144547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crossroads in the evaluation of paraoxonase 1 for protection against nerve agent and organophosphate toxicity.
    Valiyaveettil M; Alamneh YA; Doctor BP; Nambiar MP
    Toxicol Lett; 2012 Apr; 210(1):87-94. PubMed ID: 22301377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved pharmacokinetics and immunogenicity profile of organophosphorus hydrolase by chemical modification with polyethylene glycol.
    Novikov BN; Grimsley JK; Kern RJ; Wild JR; Wales ME
    J Control Release; 2010 Sep; 146(3):318-25. PubMed ID: 20547191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of a substituted β-cyclodextrin to prevent cyclosarin toxicity in vivo.
    Worek F; Seeger T; Zengerle M; Kubik S; Thiermann H; Wille T
    Toxicol Lett; 2014 Apr; 226(2):222-7. PubMed ID: 24561299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurotoxic disorders of organophosphorus compounds and their managements.
    Balali-Mood M; Balali-Mood K
    Arch Iran Med; 2008 Jan; 11(1):65-89. PubMed ID: 18154426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resveratrol induces catalytic bioscavenger paraoxonase 1 expression and protects against chemical warfare nerve agent toxicity in human cell lines.
    Curtin BF; Seetharam KI; Dhoieam P; Gordon RK; Doctor BP; Nambiar MP
    J Cell Biochem; 2008 Apr; 103(5):1524-35. PubMed ID: 17879943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human paraoxonase: a promising approach for pre-treatment and therapy of organophosphorus poisoning.
    Rochu D; Chabrière E; Masson P
    Toxicology; 2007 Apr; 233(1-3):47-59. PubMed ID: 17007987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rational design of organophosphorus hydrolase with high catalytic efficiency for detoxifying a V-type nerve agent.
    Jeong YS; Choi JM; Kyeong HH; Choi JY; Kim EJ; Kim HS
    Biochem Biophys Res Commun; 2014 Jul; 449(3):263-7. PubMed ID: 24824182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Degradation of nerve agents by an organophosphate-degrading agent (OpdA).
    Dawson RM; Pantelidis S; Rose HR; Kotsonis SE
    J Hazard Mater; 2008 Sep; 157(2-3):308-14. PubMed ID: 18258361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood acylpeptide hydrolase activity is a sensitive marker for exposure to some organophosphate toxicants.
    Quistad GB; Klintenberg R; Casida JE
    Toxicol Sci; 2005 Aug; 86(2):291-9. PubMed ID: 15888665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Organophosphates, serine esterase inhibition, and modeling of organophosphate toxicity.
    Chambers J; Oppenheimer SF
    Toxicol Sci; 2004 Feb; 77(2):185-7. PubMed ID: 14992203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emergence of catalytic bioscavengers against organophosphorus agents.
    Masson P; Lushchekina SV
    Chem Biol Interact; 2016 Nov; 259(Pt B):319-326. PubMed ID: 26899146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.